Assessment of treatment response using Computed Tomography (CT) tumor volume measurements and lesion number in metastatic urothelial carcinoma (mUC) patients (pts) receiving cabozantinib.

Author(s): Allette Kimaada,  Pattanayak Puskar,  Steinberg Seth M.,  Parnes Howard,  Jackson Gloria,  Francis Deneise,  Lamping Elizabeth,  Folio Les,  Apolo Andrea Borghese

Journal: J Clin Oncol

Date: 2015 May 20

Major Program(s) or Research Group(s): PUCRG

PubMed ID:

PMC ID: not available